In a retrospective study on T1a/b cancer patients that had RP, researchers recommended that patients that had both a PSA density of ≤0.08 after BPH surgery as well as invisible cancer lesion with no visible lesions on MRI be considered for active surveillance [30]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.